ArticleDermatology and therapy2026

Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib.

Michael DePietro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.